market coverage

Australian Securities Exchange research

Australian Securities Exchange coverage collects every dated dive and session brief on ASX-listed companies, newest first.

59 editions linked in this hub.

Coverage

  1. ASX's results rally prices a cleaner technology reset before CHESS 2ASX Limited (ASX:ASX) rose 5% after FY25 earnings growth. We test whether rate income can offset CHESS 2 and regulatory cost.
  2. Nick Scali's results pop prices sofa demand before the margin cycle turnsNick Scali (ASX:NCK) jumped after FY26 profit beat subdued furniture demand. We test whether margins or orders carry the next leg.
  3. Alliance Aviation's Qantas pop prices fleet certainty before FY26 lease returnsAlliance Aviation (ASX:AQZ) jumped after revised Qantas wet-lease terms. We test whether fleet certainty fixes the cash-return problem.
  4. AMP's profit pop prices capital returns before bank runoff is finishedAMP Limited (ASX:AMP) jumped after 1H26 profit and a new buyback. The test is whether flows, not runoff capital, now drive value.
  5. Neuren's DAYBUE pop prices a royalty upgrade before Japan answersNeuren Pharmaceuticals (ASX:NEU) jumped after DAYBUE sales upgraded royalties; we test whether the rally outruns pipeline proof.
  6. Credit Corp's results selloff prices US growth as a quality problemCredit Corp (ASX:CCP) fell 8.65% after record FY2026 profit. We test whether US growth quality offsets the headline result.
  7. FleetPartners' bid rally prices SG Fleet's synergies before the board has a dealFleetPartners (ASX:FPR) jumped on SG Fleet's $3.60 approach. The test is whether fleet-finance cash flow, not certainty, supports the move.
  8. Worley's contract pop puts backlog quality ahead of the FY26 resultWorley (ASX:WOR) rose after two services wins. We test whether the contracts change earnings power before the FY26 result.
  9. When ASX rallies priced clean execution and falls priced trustThis week's ASX moves in MGH, APX, MIN, CSL, DRO and WEB separated operational proof from trust and balance-sheet risk.
  10. Maas approval rally prices a cleaner exit than the debt story allowsMAAS Group (ASX:MGH) rose after ACCC approval for its Heidelberg sale. We examine whether cleaner focus offsets leverage and cyclicality.
  11. Appen's quarterly pop prices AI-data growth before margin proofAppen Limited (ASX:APX) jumped after Q2 FY26 revenue and EBITDA improved; the question is whether China-led AI data demand can fund margins.
  12. Mineral Resources' quarterly rally puts lithium cash against debt repairMineral Resources (ASX:MIN) rose after its FY26 quarterly update. We test whether execution offsets lithium prices and debt.
  13. CSL's Horizon 2 rally prices yield optionality before trials beginCSL (ASX:CSL) jumped after its Horizon 2 plasma update. We test whether yield upside can offset the later trial clock.
  14. DroneShield's ASIC selloff puts contract quality ahead of defence demandDroneShield (ASX:DRO) fell 13% after an ASIC-probe report. The question is whether disclosure risk changes the growth maths.
  15. WEB's buyback rally prices WebBeds margin recovery before FX does the workWeb Travel Group (ASX:WEB) jumped on 1H27 guidance and a A$90m buyback. We test whether the rally fits WebBeds' cash recovery.
  16. Resolute's ABC selloff puts growth ounces against Mali cash riskResolute Mining (ASX:RSG) fell after its ABC resource update. We test whether growth ounces offset Mali cash-flow risk.
  17. Karoon's Bauna-led pop asks if cash flow matters more than decline riskKaroon Energy (ASX:KAR) jumped after its June-quarter update. We test whether Bauna cash flow offsets reserve and decline risk.
  18. OFX's bid surge prices a cleaner exit than the payments record has earnedOFX Group (ASX:OFX) jumped 69% after the close-screen bid repricing. We test whether the payment platform's record supports the new price.
  19. James Hardie's results pop puts AZEK synergies behind the siding beatJames Hardie (ASX:JHX) jumped after preliminary Q1 FY27 sales beat guidance; the question is whether siding strength offsets AZEK debt.
  20. Peninsula's guidance withdrawal turns Lance into a flow-rate testPeninsula Energy (ASX:PEN) fell after CY2026 guidance was pulled; the issue is whether Lance has a timing problem or a funding problem.
  21. Xero's software selloff puts growth duration before Melio synergiesXero (ASX:XRO) fell in early trade; the test is whether software-duration risk now outweighs its Melio payment option.
  22. HUB24's platform selloff puts flow quality before FY26 margin reliefHUB24 (ASX:HUB) fell after its Q4 FY26 update; the issue is whether flows still justify platform-style operating leverage.
  23. Forrest's tungsten stake turns a supply-chain rally into a production testEQ Resources (ASX:EQR) jumped after Andrew Forrest's vehicle took Oaktree's stake. We test whether tungsten scarcity supports the move.
  24. Coles' relief rally says pet-care discipline matters more than new growthColes Group (ASX:COL) rallied after ending Greencross talks. The test is whether capital discipline beats buying pet-care growth.
  25. Regis lifted production guidance and still sold off with goldRegis Resources (ASX:RRL) fell about 9% after lifting FY27 output guidance. The question is whether gold-stock risk swamped mine evidence.
  26. REA's India exit rally prices cleaner margins before Aurum paperREA Group (ASX:REA) rose 6.6% before an India sale that cuts FY26 EBITDA drag. We test whether cleaner margins offset retained Aurum exposure.
  27. BHP's copper-led rally prices China's policy tailwind before iron ore does the workBHP Group (ASX:BHP) jumped 3.2% with the commodity tape. We test whether copper growth can carry an iron-ore-priced giant.
  28. Paladin's quarterly selloff puts Langer Heinrich's ramp-up before the uranium pricePaladin Energy (ASX:PDN) fell after its June-quarter call notice. We test whether the move fits Langer Heinrich ramp-up risk.
  29. IGO's battery-metals selloff puts Greenbushes cash flow before the nickel resetIGO Limited (ASX:IGO) fell 10.1% as lithium and nickel sentiment cracked. We test whether Greenbushes cash flow offsets the nickel reset.
  30. ResMed's sleep-apnoea selloff tests whether GLP-1 fear can outweigh device evidenceResMed (ASX:RMD) fell 4.7% as sleep-apnoea sentiment weakened. We test whether device demand still supports the valuation.
  31. Mesoblast's Ryoncil pop prices a launch before cash discipline is provenMesoblast (ASX:MSB) jumped on Ryoncil revenue. The question is whether the first US$115m year changes the cash-burn valuation math.
  32. Jumbo's guidance pop prices Dream US before UK integration is settledJumbo Interactive (ASX:JIN) jumped after lifting FY26 earnings expectations. The question is whether Dream US offsets the UK integration risk.
  33. Megaport's entitlement-offer rally puts funded growth back on trialMegaport (ASX:MP1) jumped after completing its retail entitlement offer. The test is whether funded network growth can earn the higher price.
  34. GenusPlus' Telstra outage selloff tests whether one contract can reset a grid-growth storyGenusPlus Group (ASX:GNP) fell after a Telstra outage clarification; we test contract risk against grid capex and cash returns.
  35. Alkane's gold output beat still left the market watching costsAlkane Resources (ASX:ALK) fell after top-half FY26 output and a cash build; the question is whether costs and merger integration explain the tape.
  36. Netwealth's Morgan Stanley pop prices platform flow before margin paybackNetwealth Group (ASX:NWL) jumped 6.7% after a Morgan Stanley platform deal; the question is how much flow can outrun FY27 spend.
  37. WiseTech's relief rally still has to carry e2open's debtWiseTech Global (ASX:WTC) jumped about 9% as software risk eased; the test is whether CargoWise returns can absorb e2open debt.
  38. Boss's guidance pop brings Honeymoon's August study to the centreBoss Energy (ASX:BOE) rose after FY26 output met guidance; the August Honeymoon study now carries the valuation burden.
  39. Vault's superior bid turns Leonora scale into the auction priceVault Minerals (ASX:VAU) jumped after Genesis topped Regis; the question is whether Leonora synergies explain the new price.
  40. Genesis' gold rally asks whether Leonora can earn the price of growthGenesis Minerals (ASX:GMD) jumped 16.7% after meeting FY26 output guidance. We test whether Leonora growth supports the rerate.
  41. PEXA's property-settlement selloff puts UK losses against the Australian toll boothPEXA Group (ASX:PXA) fell about 14% as the market tested whether UK losses can overwhelm its Australian settlement exchange.
  42. NAB's upgrade pop asks whether business-bank spreads can outrun bad debtsNational Australia Bank (ASX:NAB) jumped after an upgrade. We test whether business-bank spreads and credit quality support the move.
  43. NEXTDC's data-centre selloff tests how much AI demand can outrun capexNEXTDC (ASX:NXT) fell about 4.6% intraday. We test whether AI data-centre demand offsets capex, debt and valuation duration.
  44. Perpetual's rejected bid turns a rally into a break-up value testPerpetual (ASX:PPT) jumped after rejecting a takeover approach. The question is whether control value outruns a messy earnings rebuild.
  45. South32's aluminium exit turns a rally into a copper and manganese questionSouth32 (ASX:S32) jumped after a US$5.6b aluminium sale. The question is whether a cleaner portfolio offsets lost cash flow.
  46. Zip's two-day rally prices a US turnaround before credit costs have finished their sayZip Co (ASX:ZIP) rallied again as payments risk came back into favour; the question is whether US cash profit can outrun credit costs.
  47. Liontown's lithium selloff puts Kathleen's ramp-up before the price cycleLiontown (ASX:LTR) fell with lithium names despite a stronger March quarter; the question is whether price beta is drowning out ramp-up evidence.
  48. Transurban's North America update puts toll growth against rate riskTransurban (ASX:TCL) fell 4.4% after a North America update. We test whether traffic-linked toll growth offsets debt, capex and project risk.
  49. Neuren's European Daybue jump puts one-drug royalties ahead of the pipelineNeuren (ASX:NEU) jumped after Daybue won an EU approval positive opinion; the question is how much royalty duration the tape just capitalised.
  50. a2 Milk's A$300m payout rides China-label registrations, not a birth-rate turna2 Milk (ASX:A2M) is paying out A$300m on the back of China-label registrations, not a birth-rate turn — can share gains outrun a shrinking market?
  51. Northern Star tracks bullion higher but the market still won't pay for record gold marginsNorthern Star (ASX:NST) is riding record gold prices, yet the market still won't pay for the margins. We test whether KCGM and Hemi can convert bullion into cash.
  52. Worley's A$110m FY26 hit is timing and currency; the tape priced a structural resetWorley (ASX:WOR) took an A$110m hit from timing and currency, but the tape priced a structural reset — do delayed Middle East awards convert to backlog?
  53. Judo's credit reset turns a growth-bank story into a cost-of-risk argumentJudo Bank's credit downgrade erased about 40% of ASX:JDO. We test whether three bad loans are idiosyncratic or a structural cost-of-risk reset.
  54. Pro Medicus's contract wins are real; its 160-times multiple is the wagerPro Medicus (ASX:PME) keeps winning marquee US imaging contracts, but a ~160x multiple is the real wager. We test whether 20%+ growth can outrun the valuation.
  55. Santos shed its takeover premium just as Barossa and Pikka come onlineSantos (ASX:STO) shed its takeover premium just as Barossa and Pikka come online. We test whether the ~30% production step-up converts to free cash as oil cools.
  56. Woodside has surrendered most of its oil-war spike, leaving the LNG build to set the priceWoodside (ASX:WDS) has given back most of its oil-war price spike, leaving the Scarborough LNG build to set the story — does the growth bill convert to cash?
  57. China's export blacklist re-rated Lynas from price-taker to strategic assetChina's rare-earth export blacklist re-rated Lynas (ASX:LYC) from price-taker to strategic asset. We test whether the NdPr premium and ex-China supply case hold.
  58. MinRes wears the lithium selloff hardest because of the A$5.3bn behind itMineral Resources (ASX:MIN) wore the lithium selloff hardest because of the A$5.3bn debt behind it — can Onslow Iron carry the group until spodumene recovers?
  59. Pilbara's P2000 down payment lands in a lithium selloff it didn't causePilbara Minerals (ASX:PLS) put money down on its P2000 expansion into a lithium selloff it didn't cause — does its low-cost position justify growth at the trough?